Related Experiment Video
Updated: Dec 24, 2025
Monitoring Astrocyte Reactivity and Proliferation in Vitro Under Ischemic-Like Conditions
Published on: October 21, 2017
Effects of Mitofusin2 on astrocytes proliferation in vitro induced by scratch injury
Yulong Shi1, Peng Luo2, Chengla Yi3
1Department of Traumatic Surgery, Tong-Ji Hospital, Tongji Medical College, Jie Fang Avenue 1095, Wuhan, China; Department of Orthopedics, Xinhua Hospital of Hubei Province, Hankou District, Wuhan, China.
Abstract:
Reactive astrogliosis, a common phenomenon after central nervous system (CNS) injury, exerts negative effects on neuronal repair and recovery by forming a glial scar. Mitofusin2 (Mfn2), a hyperplasia suppression gene, is a potential target of therapeutics to better control astrogliosis. To simulate traumatic injury of the CNS in vivo, an in vitro scratch injury model was established to investigate the role of Mfn2 in the proliferation of astrocytes in this study. We demonstrated that scratch-injury stimulation upregulated the expression of the markers cyclin D1, PCNA and GFAP and turned quiescent astrocytes into mitotic cells, which may have been via activation of Ras-Raf1-ERK1/2 and PI3K-Akt signaling. Meanwhile, both the gene and protein of Mfn2 were markedly inhibited. Furthermore, overexpression of Mfn2 effectively attenuated astrocyte proliferation and halted the cell cycle, concomitant with marker downregulation and wound healing suppression. Our results demonstrate that overexpression of Mfn2 inhibits the reactive astrogliosis process by blocking the Raf1-ERK1/2 and PI3K-Akt signal pathways. Therapeutic approaches that target Mfn2 may have protective effects against reactive gliosis and glia formation.
Insights
Mitofusin2 (Mfn2) inhibits reactive astrogliosis, a detrimental process after central nervous system (CNS) injury. Overexpressing Mfn2 reduces astrocyte proliferation and glial scar formation, offering therapeutic potential.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Reactive astrogliosis impedes neuronal repair after CNS injury by forming glial scars.
- Mitofusin2 (Mfn2), a hyperplasia suppression gene, is explored as a therapeutic target to modulate astrogliosis.
Purpose of the Study:
- To investigate the role of Mfn2 in astrocyte proliferation following simulated CNS injury.
- To elucidate the signaling pathways involved in Mfn2-mediated regulation of astrogliosis.
Main Methods:
- An in vitro scratch injury model was used to simulate traumatic CNS injury.
- Expression levels of Mfn2, cyclin D1, PCNA, and GFAP were analyzed.
- Ras-Raf1-ERK1/2 and PI3K-Akt signaling pathways were investigated.
- Mfn2 overexpression was performed to assess its effects on astrocyte proliferation.
Main Results:
- Scratch injury upregulated astrocyte proliferation markers (cyclin D1, PCNA, GFAP) and inhibited Mfn2 expression.
- Injury activated Ras-Raf1-ERK1/2 and PI3K-Akt signaling pathways.
- Mfn2 overexpression attenuated astrocyte proliferation, halted the cell cycle, and suppressed wound healing.
Conclusions:
- Mfn2 overexpression inhibits reactive astrogliosis by blocking Raf1-ERK1/2 and PI3K-Akt signaling pathways.
- Targeting Mfn2 presents a potential therapeutic strategy to mitigate reactive gliosis and glial scar formation after CNS injury.
